NCT03896256View on ClinicalTrials.gov

Ketamine for Refractory Chronic Migraine: a Pilot Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 22, 2019

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Migraine Headache With Intractable Migraine
Interventions
DRUG

ketamine infusion

Ketamine will be used in subanesthetic doses for patients with refractory chronic migraine to see if it improves pain after a 5-day continuous infusion.

Trial Locations (1)

19107

Thomas Jefferson University Hospital, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT03896256 - Ketamine for Refractory Chronic Migraine: a Pilot Study | Biotech Hunter | Biotech Hunter